{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:08:14Z","timestamp":1794632894776,"version":"4.9.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>People with neuromuscular disease frequently have difficulty clearing pulmonary secretions, which leads to pneumonia and respiratory failure. High-frequency chest wall oscillation (HFCWO) is one intervention used to facilitate secretion clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this study was to determine if HFCWO therapy leads to improved outcomes as measured by lower healthcare use for patients who have a chronic neuromuscular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a cohort study comparing healthcare claims before and after initiation of HFCWO. Data were obtained from two large databases of commercial insurance claims. Study subjects were commercial insurance members with an International Classification of Diseases, Ninth Revision, code for a neuromuscular disease and a claim for HFCWO between 2007 and 2011. The study included both children and adults.<\/jats:p>\n                    <jats:p>Measurements and Main Results: There were 426 patients in this study. Their mean age was 29.9\u2009\u00b1\u200922 years. Total medical costs per member per month decreased by $1,949 (18.6%) after initiation of HFCWO (P\u2009=\u20090.002). Inpatient admission costs decreased by $2,392 (41.7%) (P\u2009=\u20090.001), and pneumonia costs decreased by $514 (18.1%) (P\u2009=\u20090.015). To account for the possibilities of misclassification based on diagnosis and bias due to loss to follow-up, we compared outcomes between those lost to follow-up and those not, and we found similar results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Total medical costs, hospitalizations, and pneumonia claims were less after than before initiation of HFCWO in a broad group of patients with neuromuscular disease. Subject to the limitations that administrative data did not capture how HFCWO was used and that HFCWO may be a marker of generally better care, our findings lend support to the routine use of this intervention in the care of patients with neuromuscular diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201509-597oc","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T18:59:34Z","timestamp":1458586774000},"page":"904-909","source":"Crossref","is-referenced-by-count":43,"title":["The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases"],"prefix":"10.1093","volume":"13","author":[{"given":"Noah","family":"Lechtzin","sequence":"first","affiliation":[{"name":"Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Frick","sequence":"additional","affiliation":[{"name":"Carey Business School and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"2026020502551723200_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0272-5231(21)00967-9","article-title":"Assessment of ventilatory function in patients with neuromuscular disease","volume":"15","author":"Rochester","year":"1994","journal-title":"Clin Chest Med"},{"key":"2026020502551723200_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.200307-885ST","article-title":"Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement","volume":"170","author":"Finder","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502551723200_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbadis.2006.06.009","article-title":"Current treatment of adult Duchenne muscular dystrophy","volume":"1772","author":"Wagner","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"2026020502551723200_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/146608202317576480","article-title":"Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment","volume":"3","author":"Lechtzin","year":"2002","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"2026020502551723200_bib5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"2026020502551723200_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00002060-199707000-00017","article-title":"Amyotrophic lateral sclerosis: successful treatment of mucous plugging by mechanical insufflation-exsufflation","volume":"76","author":"Hanayama","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"2026020502551723200_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.56.6.753","article-title":"Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes","volume":"56","author":"Lechtzin","year":"2001","journal-title":"Neurology"},{"key":"2026020502551723200_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1183\/09031936.00182208","article-title":"Chronic respiratory care for neuromuscular diseases in adults","volume":"34","author":"Ambrosino","year":"2009","journal-title":"Eur Respir J"},{"key":"2026020502551723200_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/0883073808314962","article-title":"Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population","volume":"23","author":"Ouyang","year":"2008","journal-title":"J Child Neurol"},{"key":"2026020502551723200_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0883073809350223","article-title":"Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial","volume":"25","author":"Yuan","year":"2010","journal-title":"J Child Neurol"},{"key":"2026020502551723200_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/01.WNL.0000092018.56823.02","article-title":"Cough augmentation in amyotrophic lateral sclerosis","volume":"61","author":"Mustfa","year":"2003","journal-title":"Neurology"},{"key":"2026020502551723200_bib12","first-page":"350","article-title":"Airway clearance in neuromuscular weakness","volume":"51","author":"Gauld","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"2026020502551723200_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1378\/chest.88.3.436","article-title":"Does chest physical therapy work?","volume":"88","author":"Kirilloff","year":"1985","journal-title":"Chest"},{"key":"2026020502551723200_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4187\/respcare.02217","article-title":"Adjunct therapies during mechanical ventilation: airway clearance techniques, therapeutic aerosols, and gases","volume":"58","author":"Kallet","year":"2013","journal-title":"Respir Care"},{"key":"2026020502551723200_bib15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","article-title":"Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"key":"2026020502551723200_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0873-2159(15)31254-X","article-title":"High frequency chest wall oscillation plus mechanical in-exsufflation in Duchenne muscular dystrophy with respiratory complications related to pandemic influenza A\/H1N1","volume":"16","author":"Crescimanno","year":"2010","journal-title":"Rev Port Pneumol"},{"key":"2026020502551723200_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/01.wnl.0000237439.78935.46","article-title":"High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial","volume":"67","author":"Lange","year":"2006","journal-title":"Neurology"},{"key":"2026020502551723200_bib18","first-page":"A669","article-title":"A cost analysis of high-frequency chest wall oscillation in cystic fibrosis [abstract]","volume":"149","author":"Ohnsorg","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502551723200_bib19","first-page":"A6309","article-title":"The impact of high frequency chest wall oscillation on healthcare utilization in patients with neuromuscular diseases [abstract]","volume":"191","author":"Lechtzin","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502551723200_bib20","doi-asserted-by":"crossref","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS One"},{"key":"2026020502551723200_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamasurg.2013.131","article-title":"Impact of minimally invasive surgery on medical spending and employee absenteeism","volume":"148","author":"Epstein","year":"2013","journal-title":"JAMA Surg"},{"key":"2026020502551723200_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.spinee.2006.09.006","article-title":"An economic model of one-level lumbar arthroplasty versus fusion","volume":"7","author":"Guyer","year":"2007","journal-title":"Spine J"},{"key":"2026020502551723200_bib23","volume-title":"Fundamentals of general insurance actuarial analysis.","author":"Friedland","year":"2013"},{"key":"2026020502551723200_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4187\/respcare.02446","article-title":"High-frequency chest wall compression therapy in neurologically impaired children","volume":"59","author":"Fitzgerald","year":"2014","journal-title":"Respir Care"},{"key":"2026020502551723200_bib25","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1378\/chest.128.5.3377","article-title":"Assessing efficacy of high-frequency chest wall oscillation in patients with familial dysautonomia","volume":"128","author":"Giarraffa","year":"2005","journal-title":"Chest"},{"key":"2026020502551723200_bib26","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.STR.29.8.1602","article-title":"Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes","volume":"29","author":"Goldstein","year":"1998","journal-title":"Stroke"},{"key":"2026020502551723200_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0895-4356(02)00409-2","article-title":"Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study","volume":"55","author":"Chi\u00f2","year":"2002","journal-title":"J Clin Epidemiol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/6\/904\/66768277\/annalsats_13_6_904.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/6\/904\/66768277\/annalsats_13_6_904.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:55:27Z","timestamp":1770278127000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/6\/904\/8447441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201509-597oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,6]]},"published":{"date-parts":[[2016,6,1]]}}}